Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer treatment: The killer within.

× No keyword cloud information.

17 in total

Review 1. Intratumoral dendritic cells in the anti-tumor immune response.

Authors: Yang Liu; Xuetao Cao
Journal: Cell Mol Immunol Date: 2015-01-19 Impact factor: 11.530

2. Combining Nanomedicine and Immunotherapy.

Authors: Yang Shi; Twan Lammers
Journal: Acc Chem Res Date: 2019-05-23 Impact factor: 22.384

3. Low reactivity of tumor MUC1-binding natural anti-α-galactoside antibody is a risk factor for breast cancer.

Authors: Jessy John; Kurian Cherian; Thomas Abraham; Padinjaradath S Appukuttan
Journal: Exp Biol Med (Maywood) Date: 2020-01-19

4. Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells.

Authors: Mahboubeh Yazdanifar; Ru Zhou; Pinku Mukherjee
Journal: Curr Trends Immunol Date: 2016

Review 5. Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case study.

Authors: David J Klinke
Journal: J Immunother Cancer Date: 2015-06-16 Impact factor: 13.751

6. Immunomodulatory Response Triggered by the Alkaloids, 3-Amino-7-Benzylbenzimidazo[3,2-a] Quinolinium Chloride (ABQ-48) and 3-Nitro-7-Benzylbenzimidazo [3,2-a] Quinolinium Chloride (NBQ-48).

Authors: Miguel Otero; Beatriz Zayas; Eric Miranda; Christian Velez; Wigberto J Hernandez; Luis A Rivera; Osvaldo Cox
Journal: J Cancer Res Ther Oncol Date: 2015-05-04

Review 7. Single-cell analysis tools for drug discovery and development.

Authors: James R Heath; Antoni Ribas; Paul S Mischel
Journal: Nat Rev Drug Discov Date: 2015-12-16 Impact factor: 112.288

8. Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma.

Authors: Mark R Middleton; Cheryl McAlpine; Victoria K Woodcock; Pippa Corrie; Jeffrey R Infante; Neil M Steven; Thomas R Jeffry Evans; Alan Anthoney; Alexander N Shoushtari; Omid Hamid; Avinash Gupta; Antonella Vardeu; Emma Leach; Revashnee Naidoo; Sarah Stanhope; Sion Lewis; Jacob Hurst; Ita O'Kelly; Mario Sznol
Journal: Clin Cancer Res Date: 2020-08-18 Impact factor: 13.801

9. What have we learned from cancer immunotherapy in the last 3 years?

Authors: Paolo A Ascierto; Francesco M Marincola
Journal: J Transl Med Date: 2014-05-21 Impact factor: 5.531

10. Interferon-γ and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironment.

Authors: Fuqiang Ren; Mingyu Fan; Jiandong Mei; Yongqiang Wu; Chengwu Liu; Qiang Pu; Zongbing You; Lunxu Liu
Journal: Drug Des Devel Ther Date: 2014-09-23 Impact factor: 4.162